Clin2
NCT07277712Likely a fitNot yet recruiting

Study of a new tablet for healthy adults

Healthy Volunteer

Treatments studied

This study tests a new tablet in healthy adults to see how the body processes it and whether food changes its effects. It helps determine the right dose and safety for future patients.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
74 people
Ages
19 years to 55 years
Study type
Interventional

Who can take part

  • You are between 19 and 55 years old.
  • Your body mass index (BMI) is between 19 and 27, and you weigh at least 45 kg.
  • You are generally healthy, with no significant medical conditions.
  • You have not taken any other investigational drug in the last 6 months.
  • You do not drink more than 210 grams of alcohol per week (about 21 standard drinks).
  • You are willing to eat a high-fat meal during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07853248Not yet recruiting· Phase 1
Study of tegoprazan and aspirin interaction in healthy men

This trial studies how two medicines, toprazole and aspirin, interact in healthy men. You'll take both and have your blood tested to see how your body handles them.

Seoul
NCT07311811Not yet recruiting· Phase 1
Study of two new drugs in healthy volunteers

This study tests two investigational drugs in healthy adults to see how the body absorbs, breaks down, and eliminates them, and to check for any side effects. If you are a healthy adult, you may be able to help researchers understand these drugs better.

Seoul
NCT07811063Not yet recruiting· Phase 1
Testing a new tablet in healthy adults

This study tests a single dose of a new tablet medication (called TRTL-729) in healthy adults. It helps researchers learn how the drug is absorbed and tolerated, which is a first step in developing a treatment.

Auckland
NCT06867406Not yet recruiting· Phase 1
Safety study of a new tablet in healthy adults

This trial tests a new tablet drug in healthy people to see how safe it is and how the body processes it. It is an early-stage study, meaning it helps find the right dose and check for side effects.

Beijing, Beijing Municipality
NCT07792928Not yet recruiting· Phase 1
Study of a new tablet in healthy adults

This study tests a new investigational tablet in healthy adults to see how the body handles it and if it's safe. The results will help guide future research.

Takapuna, Auckland
NCT07703904Not yet recruiting· Phase 1
Safety study of a new oral tablet in healthy volunteers

This study tests a new slow-release tablet (Hemay5259) in healthy people. It aims to check how safe the drug is, how it works in the body, and whether food changes its effects. Participants will receive the drug and be closely monitored for side effects.

Randwick, New South Wales

Hear when a new Healthy Volunteer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.